5-Years Analysis of Effectivity and Toxicity of Ultra-Hypofractionated Proton Radiotherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer—A Retrospective Analysis

SIMPLE SUMMARY: This retrospective study presents the clinical outcomes of the largest cohort of patients (853 patients) with low-, favorable intermediate-, and unfavorable intermediate-risk prostate cancer treated with ultra-hypofractionated proton beam radiotherapy (36.25 GyE/five fractions). The...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubeš, Jiri, Sláviková, Silvia, Vítek, Pavel, Haas, Alexandra, Ondrová, Barbora, Dedečková, Kateřina, Andrlík, Michal, Domanský, Martin, Jiránková, Kateřina, Schlencová, Veronika, Harazimová, Anh, Turková, Barbora, Doležal, Tomáš, Al-Hamami, Sarah Falah Abass, Vondráček, Vladimír
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526468/
https://www.ncbi.nlm.nih.gov/pubmed/37760540
http://dx.doi.org/10.3390/cancers15184571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526468/
https://www.ncbi.nlm.nih.gov/pubmed/37760540
http://dx.doi.org/10.3390/cancers15184571

Ejemplares similares